Oral Proteins And Peptides Global Market Report 2025

Global Oral Proteins And Peptides Market Report 2024

Oral Proteins And Peptides Global Market Report 2025 – By Drug Type (Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide), By Biological Target (Guanylate Cyclase-C (GC-C), Insulin Receptor, Oxalate, Other Biological Targets), By Mechanism Of Action (Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action), By Application (Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer) – Market Size, Trends, And Global Forecast 2025-2034

Name: Oral Proteins And Peptides Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Oral Proteins And Peptides Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Oral Proteins And Peptides Global Market Report 2025

Proud Members Of

Oral Proteins And Peptides Market Definition

Oral Proteins and Peptides refer to therapeutic proteins and peptides administered orally, typically in pills, capsules, or other ingestible formats. These biologically active molecules are designed to treat various medical conditions by leveraging their specific actions within the body.

The main drug types of oral proteins and peptides are linaclotide, calcitonin, Insulin, plecanatide, and octreotide. The biological targets are guanylate cyclase-c (gc-c), insulin receptor, oxalate, and others, and the different mechanisms of action are receptor stimulation, substrate degradation, and others. It is used for various applications such as gastrointestinal disorders, bone disease, Neurological Disorders, diabetes, metabolic disorders, hormonal disorders, and cancer.

Oral Proteins And Peptides Market Segmentation

The oral proteins and peptidesmarket covered in this report is segmented –

1) By Drug Type: Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide

2) By Biological Target: Guanylate Cyclase-C (GC-C), Insulin Receptor, Oxalate, Other Biological Targets

3) By Mechanism Of Action: Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action

4) By Application: Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer

Subsegments:

1) By Linaclotide: Indications For Irritable Bowel Syndrome (IBS), Indications For Chronic Idiopathic Constipation (CIC)

2) By Calcitonin: Calcitonin-Salmon, Synthetic Calcitonin, Calcitonin for Osteoporosis Treatment

3) By Insulin: Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin Products, Oral Insulin Formulations

4) By Plecanatide: Indications For Chronic Idiopathic Constipation (CIC), Indications For Irritable Bowel Syndrome With Constipation (IBS-C)

5) By Octreotide: Long-Acting Octreotide Formulations, Short-Acting Octreotide Formulations, Indications For Acromegaly And Neuroendocrine Tumors

Oral Proteins And Peptides Market Size and growth rate 2025 to 2029: Graph

Oral Proteins And Peptides Market Size 2025 And Growth Rate

The oral proteins and peptides market size has grown exponentially in recent years. It will grow from $1.27 billion in 2024 to $1.56 billion in 2025 at a compound annual growth rate (CAGR) of 22.7%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, increasing investments in biotechnology for the development of oral protein-based treatments, growing consumer preference for non-invasive treatments, increasing biopharmaceutical industry, and rising focus on personalized medicine.

Oral Proteins And Peptides Market Growth Forecast

The oral proteins and peptides market size is expected to see exponential growth in the next few years. It will grow to $3.49 billion in 2029 at a compound annual growth rate (CAGR) of 22.3%. The growth in the forecast period can be attributed to increasing focus on patient-centric drugs, increasing prevalence of the geriatric population, rising healthcare expenditure, growing need for diagnostics in cancer, and rising preference for oral drugs. Major trends in the forecast period include development of novel oral peptides with enhanced stability and efficacy, integration of artificial intelligence in drug discovery processes for oral formulations, advanced medical treatments, advancements in drug delivery technologies, and innovative oral insulin formulations.

Book your 30 minutes free consultation with our research experts

Oral Proteins And Peptides Market Driver: Growing Biopharmaceutical Industry

The growing biopharmaceutical industry is expected to propel the growth of the oral proteins and peptides market going forward. The biopharmaceutical industry is a sector within the broader pharmaceutical industry that focuses on developing, producing, and commercializing drugs derived from biological sources. The growth of the biopharmaceutical industry is due to advancements in biotechnology, growing demand for personalized medicine, increasing prevalence of chronic diseases, and rising investment in research and development. Oral proteins and peptides in biopharmaceuticals offer potential for non-invasive delivery of therapeutics, enhancing patient compliance and reducing the need for injections. They can target specific diseases with improved stability and absorption in the digestive system. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based European trade association representing the pharmaceutical industry, the total bio-pharmaceutical production in Europe accounted for $384,200 million (€340,000 million) in 2022, an increase of approximately 4.95% from $366,267 million (€323,950 million) in 2021. Therefore, the growing biopharmaceutical industry is driving the growth of the oral proteins and peptides market.

Global Oral Proteins And Peptides Market Major Players

Major companies operating in the oral proteins and peptides market are Pfizer Inc., Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Ipsen S.A., Biocon Limited, Xeris Pharmaceuticals Inc., Adocia S.A., Zealand Pharma A/S, Diabetology Ltd., Oramed Pharmaceuticals Inc., Palatin Technologies Inc., Entera Bio Ltd.

Global Oral Proteins And Peptides Market Trend: Breakthrough Oral Insulin Technologies In Diabetes Care

Major companies operating in the oral proteins and peptides market are focusing on developing innovative products, such as Oral Semaglutide, to enhance patient adherence and comfort. Oral semaglutide is a groundbreaking medication that significantly advances oral proteins and peptides. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, traditionally administered via injection to treat type 2 diabetes and, more recently, obesity. For instance, in January 2022, Novo Nordisk India, an India-based healthcare company, launched the world's first oral semaglutide, marking a revolutionary advance in diabetes treatment. Semaglutide is a GLP-1 receptor analogue (GLP-1 RA) previously available only in injectable form, now offers a more convenient oral option for managing type 2 diabetes. This breakthrough not only transforms diabetes care but also sets the stage for future innovations in oral insulin formulations, potentially leading to more effective and patient-friendly treatment options.

Oral Proteins And Peptides Market Merger And Acquisition: Chiesi Acquires Amryt Pharma To Strengthen Rare Disease Focus And Biopharmaceutical Capabilities

In April 2023, Chiesi Farmaceutici S.p.a., an Italy-based pharmaceutical company, acquired Amryt Pharma Plc for an undisclosed amount. This acquisition enables Chiesi to harness Amryt's distinctive products and promising pipeline, reinforcing its dedication to rare diseases and enhancing its biopharmaceutical capabilities. Amryt Pharma Plc is a UK-based provider of oral proteins and peptides.

Regional Outlook For The Global Oral Proteins And Peptides Market

North America was the largest region in the oral proteins and peptides market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral proteins and peptides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oral proteins and peptides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oral Proteins And Peptides Market?

The oral proteins and peptides market consists of sales of protein supplements, peptide-based drugs, and therapeutic formulations designed for oral administration. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Oral Proteins And Peptides Industry?

The oral proteins and peptides market research report is one of a series of new reports from The Business Research Company that provides oral proteins and peptides market statistics, including oral proteins and peptides industry global market size, regional shares, competitors with a oral proteins and peptides market share, detailed oral proteins and peptides market segments, market trends and opportunities, and any further data you may need to thrive in the oral proteins and peptides industry. This oral proteins and peptides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Oral Proteins And Peptides Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.56 billion
Revenue Forecast In 2034	$3.49 billion
Growth Rate	CAGR of 22.3% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Drug Type: Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide 2) By Biological Target: Guanylate Cyclase-C (GC-C), Insulin Receptor, Oxalate, Other Biological Targets 3) By Mechanism Of Action: Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action 4) By Application: Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer Subsegments: 1) By Linaclotide: Indications For Irritable Bowel Syndrome (IBS), Indications For Chronic Idiopathic Constipation (CIC) 2) By Calcitonin: Calcitonin-Salmon, Synthetic Calcitonin, Calcitonin for Osteoporosis Treatment 3) By Insulin: Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin Products, Oral Insulin Formulations 4) By Plecanatide: Indications For Chronic Idiopathic Constipation (CIC), Indications For Irritable Bowel Syndrome With Constipation (IBS-C) 5) By Octreotide: Long-Acting Octreotide Formulations, Short-Acting Octreotide Formulations, Indications For Acromegaly And Neuroendocrine Tumors
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Ipsen S.A., Biocon Limited, Xeris Pharmaceuticals Inc., Adocia S.A., Zealand Pharma A/S, Diabetology Ltd., Oramed Pharmaceuticals Inc., Palatin Technologies Inc., Entera Bio Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Oral Proteins And Peptides Market Characteristics

3. Oral Proteins And Peptides Market Trends And Strategies

4. Oral Proteins And Peptides Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Oral Proteins And Peptides Growth Analysis And Strategic Analysis Framework

5.1. Global Oral Proteins And Peptides PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Oral Proteins And Peptides Market Growth Rate Analysis

5.4. Global Oral Proteins And Peptides Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Oral Proteins And Peptides Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Oral Proteins And Peptides Total Addressable Market (TAM)

6. Oral Proteins And Peptides Market Segmentation

6.1. Global Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Linaclotide

Calcitonin

Insulin

Plecanatide

Octreotide

6.2. Global Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Guanylate Cyclase-C (GC-C)

Insulin Receptor

Oxalate

Other Biological Targets

6.3. Global Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Receptor Stimulation

Substrate Degradation

Other Mechanisms Of Action

6.4. Global Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gastrointestinal Disorders

Bone Disease

Neurological Disorders

Diabetes

Metabolic Disorders

Hormonal Disorder

Cancer

6.5. Global Oral Proteins And Peptides Market, Sub-Segmentation Of Linaclotide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Indications For Irritable Bowel Syndrome (IBS)

Indications For Chronic Idiopathic Constipation (CIC)

6.6. Global Oral Proteins And Peptides Market, Sub-Segmentation Of Calcitonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Calcitonin-Salmon

Synthetic Calcitonin

Calcitonin for Osteoporosis Treatment

6.7. Global Oral Proteins And Peptides Market, Sub-Segmentation Of Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Rapid-Acting Insulin

Long-Acting Insulin

Combination Insulin Products

Oral Insulin Formulations

6.8. Global Oral Proteins And Peptides Market, Sub-Segmentation Of Plecanatide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Indications For Chronic Idiopathic Constipation (CIC)

Indications For Irritable Bowel Syndrome With Constipation (IBS-C)

6.9. Global Oral Proteins And Peptides Market, Sub-Segmentation Of Octreotide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Long-Acting Octreotide Formulations

Short-Acting Octreotide Formulations

Indications For Acromegaly And Neuroendocrine Tumors

7. Oral Proteins And Peptides Market Regional And Country Analysis

7.1. Global Oral Proteins And Peptides Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Oral Proteins And Peptides Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oral Proteins And Peptides Market

8.1. Asia-Pacific Oral Proteins And Peptides Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oral Proteins And Peptides Market

9.1. China Oral Proteins And Peptides Market Overview

9.2. China Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oral Proteins And Peptides Market

10.1. India Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oral Proteins And Peptides Market

11.1. Japan Oral Proteins And Peptides Market Overview

11.2. Japan Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oral Proteins And Peptides Market

12.1. Australia Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oral Proteins And Peptides Market

13.1. Indonesia Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oral Proteins And Peptides Market

14.1. South Korea Oral Proteins And Peptides Market Overview

14.2. South Korea Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oral Proteins And Peptides Market

15.1. Western Europe Oral Proteins And Peptides Market Overview

15.2. Western Europe Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oral Proteins And Peptides Market

16.1. UK Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oral Proteins And Peptides Market

17.1. Germany Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oral Proteins And Peptides Market

18.1. France Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oral Proteins And Peptides Market

19.1. Italy Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oral Proteins And Peptides Market

20.1. Spain Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oral Proteins And Peptides Market

21.1. Eastern Europe Oral Proteins And Peptides Market Overview

21.2. Eastern Europe Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oral Proteins And Peptides Market

22.1. Russia Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oral Proteins And Peptides Market

23.1. North America Oral Proteins And Peptides Market Overview

23.2. North America Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oral Proteins And Peptides Market

24.1. USA Oral Proteins And Peptides Market Overview

24.2. USA Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oral Proteins And Peptides Market

25.1. Canada Oral Proteins And Peptides Market Overview

25.2. Canada Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oral Proteins And Peptides Market

26.1. South America Oral Proteins And Peptides Market Overview

26.2. South America Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oral Proteins And Peptides Market

27.1. Brazil Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oral Proteins And Peptides Market

28.1. Middle East Oral Proteins And Peptides Market Overview

28.2. Middle East Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oral Proteins And Peptides Market

29.1. Africa Oral Proteins And Peptides Market Overview

29.2. Africa Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oral Proteins And Peptides Market Competitive Landscape And Company Profiles

30.1. Oral Proteins And Peptides Market Competitive Landscape

30.2. Oral Proteins And Peptides Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Oral Proteins And Peptides Market Other Major And Innovative Companies

31.1. Sanofi S.A.

31.2. AstraZeneca PLC

31.3. Novartis AG

31.4. GlaxoSmithKline PLC

31.5. Eli Lilly and Company

31.6. Amgen Inc.

31.7. Novo Nordisk A/S

31.8. Ipsen S.A.

31.9. Biocon Limited

31.10. Xeris Pharmaceuticals Inc.

31.11. Adocia S.A.

31.12. Zealand Pharma A/S

31.13. Diabetology Ltd.

31.14. Oramed Pharmaceuticals Inc.

31.15. Palatin Technologies Inc.

32. Global Oral Proteins And Peptides Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oral Proteins And Peptides Market

34. Recent Developments In The Oral Proteins And Peptides Market

35. Oral Proteins And Peptides Market High Potential Countries, Segments and Strategies

35.1 Oral Proteins And Peptides Market In 2029 - Countries Offering Most New Opportunities

35.2 Oral Proteins And Peptides Market In 2029 - Segments Offering Most New Opportunities

35.3 Oral Proteins And Peptides Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Linaclotide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Calcitonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Plecanatide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Octreotide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Oral Proteins And Peptides Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Oral Proteins And Peptides Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Pfizer Inc. Financial Performance

Table 81: Johnson & Johnson Services Inc. Financial Performance

Table 82: Roche Holding AG Financial Performance

Table 83: Merck & Co. Inc. Financial Performance

Table 84: AbbVie Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Linaclotide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Calcitonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Plecanatide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Octreotide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Oral Proteins And Peptides Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Oral Proteins And Peptides Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Pfizer Inc. Financial Performance

Figure 81: Johnson & Johnson Services Inc. Financial Performance

Figure 82: Roche Holding AG Financial Performance

Figure 83: Merck & Co. Inc. Financial Performance

Figure 84: AbbVie Inc. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the microbiome market research report 2022 with industry size, share, segments and market growth

Oral Biologics & Biosimilar Drugs Global Market Report 2025 – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Oral Contraceptive Pills Global Market Report 2025 – By Type (Combination, Progestin Only, Other Types), By Category (Generic, Branded), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Oral Thin Films Global Market Report 2025 – By Type (Sublingual Film, Fast Dissolving Dental/Buccal Film), By Disease Indication (Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, Other Disease Indication), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Oral Biologics & Biosimilars Global Market Report 2025 – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors, Immunostimulants, GPCR Modulators, Other Therapies), By Disease (Diabetes, Arthritis and Crohn’s Disease, Cancer, Infectious Disease, Other Autoimmune Disease, Other Diseases), By Molecule Type (Vaccines, Proteins and Peptides, Monoclonal Antibodies, Other Molecule Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Oral Care Global Market Report 2025 – By Product Type (Toothpaste, Mouth Wash and Rinse, Teeth Whitening, Dental Floss, Tooth Brush, Orthodontic Wax), By Distribution Channel (Store-based, Non-Store-Based), By End User (Hospitals, Dental Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Intraoral Cameras Global Market Report 2025 – By Type( USB Camera, Fiber Optic Camera, Wireless Cameras, Other Types), By Software Type( X-Ray Software, Button Capture Software), By Application( Implantology, Endodontic, Oral And Maxillofacial Surgery, Orthodontics, Other Applications), By End User( Dental Hospitals And Clinics, Dental Diagnostic Centers, Dental Academic And Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Behavioral and Mental Health Software Global Market Report 2025 – By Component (Support Services, Software), By Type (Clinical Software, Financial Software, Administrative Software, Other Types), By Delivery Model (Subscription Model, Ownership Model), By End-Users (Community Clinics, Hospitals, Private Practices) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Behavioral Biometrics Global Market Report 2025 – By Components (Software, Services), By Type (Keystroke Dynamics, Gait Analysis, Signature Analysis, Voice Recognition), By Deployment Model (Cloud, On-Premises), By Application (Identity Proofing, Continuous Authentication, Risk and Compliance Management, Fraud Detection and Prevention), By Verticals (Banking, Financial Services and Insurance (BFSI), Retail, e-Commerce, Healthcare, Government and Defense, Telecommunications, Other verticals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Oral Proteins And Peptides market?

How will the Oral Proteins And Peptides market drivers and restraints affect the market dynamics? What forces will shape the Oral Proteins And Peptides industry going forward?

The Oral Proteins And Peptides market major growth driver - Growing Biopharmaceutical Industry. For further insights on the Oral Proteins And Peptides market, request a sample here

What is the forecast market size or the forecast market value of the Oral Proteins And Peptides market?

The Oral Proteins And Peptides market size has grown strongly in recent years. The oral proteins and peptides market size has grown exponentially in recent years. It will grow from $1.27 $ billion in 2024 to $1.56 $ billion in 2025 at a compound annual growth rate (CAGR) of 22.7%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, increasing investments in biotechnology for the development of oral protein-based treatments, growing consumer preference for non-invasive treatments, increasing biopharmaceutical industry, and rising focus on personalized medicine. The oral proteins and peptides market size is expected to see exponential growth in the next few years. It will grow to $3.49 $ billion in 2029 at a compound annual growth rate (CAGR) of 22.3%. The growth in the forecast period can be attributed to increasing focus on patient-centric drugs, increasing prevalence of the geriatric population, rising healthcare expenditure, growing need for diagnostics in cancer, and rising preference for oral drugs. Major trends in the forecast period include development of novel oral peptides with enhanced stability and efficacy, integration of artificial intelligence in drug discovery processes for oral formulations, advanced medical treatments, advancements in drug delivery technologies, and innovative oral insulin formulations. For further insights on the Oral Proteins And Peptides market, request a sample here

How is the Oral Proteins And Peptides market segmented?

The oral proteins and peptidesmarket covered in this report is segmented –
1) By Drug Type: Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide
2) By Biological Target: Guanylate Cyclase-C (GC-C), Insulin Receptor, Oxalate, Other Biological Targets
3) By Mechanism Of Action: Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action
4) By Application: Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer
Subsegments:
1) By Linaclotide: Indications For Irritable Bowel Syndrome (IBS), Indications For Chronic Idiopathic Constipation (CIC)
2) By Calcitonin: Calcitonin-Salmon, Synthetic Calcitonin, Calcitonin for Osteoporosis Treatment
3) By Insulin: Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin Products, Oral Insulin Formulations
4) By Plecanatide: Indications For Chronic Idiopathic Constipation (CIC), Indications For Irritable Bowel Syndrome With Constipation (IBS-C)
5) By Octreotide: Long-Acting Octreotide Formulations, Short-Acting Octreotide Formulations, Indications For Acromegaly And Neuroendocrine Tumors For further insights on the Oral Proteins And Peptides market, request a sample here

Which region has the largest share of the Oral Proteins And Peptides market? What are the other regions covered in the report?

North America was the largest region in the oral proteins and peptides market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral proteins and peptides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Oral Proteins And Peptides market, request a sample here.

Who are the major players in the Oral Proteins And Peptides market?

What are the key trends in the Oral Proteins And Peptides market?

Major trends in the Oral Proteins And Peptides market include Breakthrough Oral Insulin Technologies In Diabetes Care. For further insights on the Oral Proteins And Peptides market, request a sample here.

What are the major opportunities in the Oral Proteins And Peptides market? What are the strategies for the Oral Proteins And Peptides market?

For detailed insights on the major opportunities and strategies in the Oral Proteins And Peptides market, request a sample here.

How does the Oral Proteins And Peptides market relate to the overall economy and other similar markets?

For detailed insights on Oral Proteins And Peptides's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Oral Proteins And Peptides industry?

For detailed insights on the mergers and acquisitions in the Oral Proteins And Peptides industry, request a sample here.

What are the key dynamics influencing the Oral Proteins And Peptides market growth? SWOT analysis of the Oral Proteins And Peptides market.

For detailed insights on the key dynamics influencing the Oral Proteins And Peptides market growth and SWOT analysis of the Oral Proteins And Peptides industry, request a sample here.